Literature DB >> 17394954

The tradeoff between treatment plan quality and required number of monitor units in intensity-modulated radiotherapy.

David Craft1, Philipp Süss, Thomas Bortfeld.   

Abstract

PURPOSE: To provide a mathematical approach for quantifying the tradeoff between intensity-modulated radiotherapy (IMRT) complexity and plan quality. METHODS AND MATERIALS: We solve a multi-objective program that includes IMRT complexity, measured as the number of monitor units (MU) needed to deliver the plan using a multileaf collimator, as an objective. Clinical feasibility of plans is ensured by the use of hard constraints in the formulation. Optimization output is a Pareto surface of treatment plans, which allows the tradeoffs between IMRT complexity, tumor coverage, and tissue sparing to be observed. Paraspinal and lung cases are presented.
RESULTS: Although the amount of possible MU reduction is highly dependent on the difficulty of the underlying treatment plan (difficult plans requiring a high degree of intensity modulation are more sensitive to MU reduction), in some cases the number of MU can be reduced more than twofold with a <1% increase in the objective function.
CONCLUSIONS: The largely increased number of MU and irradiation time in IMRT is sometimes unnecessary. Tools like the one presented should be considered for integration into daily clinical practice to avoid this problem.

Entities:  

Mesh:

Year:  2007        PMID: 17394954     DOI: 10.1016/j.ijrobp.2006.11.034

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  23 in total

1.  Multicriteria VMAT optimization.

Authors:  David Craft; Dualta McQuaid; Jeremiah Wala; Wei Chen; Ehsan Salari; Thomas Bortfeld
Journal:  Med Phys       Date:  2012-02       Impact factor: 4.071

2.  Balancing control and simplicity: A variable aggregation method in intensity modulated radiation therapy planning.

Authors:  Philipp Süss; Karl-Heinz Küfer
Journal:  Linear Algebra Appl       Date:  2008-03-01       Impact factor: 1.401

Review 3.  Complexity metrics for IMRT and VMAT plans: a review of current literature and applications.

Authors:  Sophie Chiavassa; Igor Bessieres; Magali Edouard; Michel Mathot; Alexandra Moignier
Journal:  Br J Radiol       Date:  2019-07-24       Impact factor: 3.039

4.  Use of plan quality degradation to evaluate tradeoffs in delivery efficiency and clinical plan metrics arising from IMRT optimizer and sequencer compromises.

Authors:  Joel R Wilkie; Martha M Matuszak; Mary Feng; Jean M Moran; Benedick A Fraass
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

5.  Including robustness in multi-criteria optimization for intensity-modulated proton therapy.

Authors:  Wei Chen; Jan Unkelbach; Alexei Trofimov; Thomas Madden; Hanne Kooy; Thomas Bortfeld; David Craft
Journal:  Phys Med Biol       Date:  2012-01-06       Impact factor: 3.609

6.  Multicriteria optimization informed VMAT planning.

Authors:  Huixiao Chen; David L Craft; David P Gierga
Journal:  Med Dosim       Date:  2013-12-19       Impact factor: 1.482

7.  Optimal partial-arcs in VMAT treatment planning.

Authors:  Jeremiah Wala; Ehsan Salari; Wei Chen; David Craft
Journal:  Phys Med Biol       Date:  2012-09-05       Impact factor: 3.609

8.  Comparison of simple and complex liver intensity modulated radiotherapy.

Authors:  Mark T Lee; Thomas G Purdie; Cynthia L Eccles; Michael B Sharpe; Laura A Dawson
Journal:  Radiat Oncol       Date:  2010-11-30       Impact factor: 3.481

9.  Evaluation of the optimal combinations of modulation factor and pitch for Helical TomoTherapy plans made with TomoEdge using Pareto optimal fronts.

Authors:  Geert De Kerf; Dirk Van Gestel; Lobke Mommaerts; Danielle Van den Weyngaert; Dirk Verellen
Journal:  Radiat Oncol       Date:  2015-09-17       Impact factor: 3.481

Review 10.  Direct aperture optimization as a means of reducing the complexity of Intensity Modulated Radiation Therapy plans.

Authors:  Maria Broderick; Michelle Leech; Mary Coffey
Journal:  Radiat Oncol       Date:  2009-02-16       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.